Sep 26, 2012
1:16
For every 16 shares held, investors received 1. The price per share adjusted from $0.34 to $0.02.
The split itself did not change the total investment value.
Northwest Biotherapeutics, Inc. (NWBO) trades on the Other OTC in the Biotechnology industry.
Northwest Biotherapeutics, Inc. company overviewThe latest split shown was on September 26, 2012. It was a 1-for-16 reverse split, so shareholders received 1 share for every 16 they held.
This history records 2 reverse splits between June 28, 2007 and September 26, 2012.